Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International journal of hematology

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03165118PMID 12430926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The TEL‐AML1 real‐time quantitative polymerase chain reaction (PCR) might replace the antigen receptor‐based genomic PCR in clinical minimal residual disease studies 
in children with acute lymphoblastic leukaemia

  2002cited by this paper
• Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.

  2002cited by this paper
• The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; Malignancy.

  2001cited by this paper
• Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR‐ABL fusion transcripts detected using a new real‐time polymerase chain reaction method

  2001cited by this paper
• Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction.

  2001cited by this paper
• Kinetics of BCR‐ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real‐time polymerase chain reaction

  2001cited by this paper
• Real‐time reverse transcription polymerase chain reaction detection and quantification of t(1;19) (E2A–PBX1) fusion genes associated with leukaemia

  2001cited by this paper
• The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease

  2000cited by this paper

• Donor Chimerism Study by Single Nucleotide Polymorphism using SYBR green based Real Time PCR

  2021cites this paper
• 19 Overview of Real-Time PCR Principles

  2017cites this paper
• Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow?

  2014cites this paper
• Validation of chimerism in pediatric recipients of allogeneic hematopoietic stem cell transplantation (HSCT) a comparison between two methods

  2013cites this paper
• Overview of Real-Time PCR Principles

  2012cites this paper
• Feasibility of a cost-effective approach to evaluate short tandem repeat markers suitable for chimerism follow-up

  2012cites this paper
• Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia

  2011cites this paper
• Current treatment concepts of CML.

  2011cites this paper
• Sex chromosome changes after sex‐mismatched allogeneic bone marrow transplantation can mislead the chimerism analysis

  2010cites this paper
• Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.

  2010cites this paper
• Evaluation diagnosis of minimal residual disease in chronic myeloid leukemia by Real-Time PCR

  2009cites this paper
• Minimal residual disease diagnostics in myeloid malignancies in the post transplant period

  2008cites this paper
• Real-time PCR Analysis of RNA Extracted From Formalin-fixed and Paraffin-embeded Tissues: Effects of the Fixation on Outcome Reliability

  2007cites this paper
• Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements

  2007cites this paper
• Use of the Activating Gene Mutation of the Tyrosine Kinase (VAL617Phe) JAK2 as a Minimal Residual Disease Marker in Patients With Myelofibrosis and Myeloid Metaplasia After Allogeneic Stem Cell Transplantation

  2007cites this paper
• Monitoramento de doença residual mínima em leucemia mielóide crônica por PCR em tempo real

  2007cites this paper
• Quantitative analysis of chimerism after allogeneic stem cell transplantation by real‐time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats,and Y‐chromosome‐specific sequences

  2006cites this paper
• Screening of copy number polymorphisms in human beta-defensin genes using modified real-time quantitative PCR.

  2006cites this paper
• Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation.

  2006cites this paper
• Development Application of Polymerase Chain Reaction (PCR)

  2006cites this paper
• Different real time PCR approaches for the fine quantification of SNP's alleles in DNA pools: assays development, characterization and pre-validation.

  2005cites this paper
• Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction.

  2005cites this paper
• valuation and Automation of Hematopoietic himerism Analysis Based on Real-Time Quantitative olymerase Chain Reaction

  2005cites this paper
• Diagnostic Chimerism Analysis After Allogeneic Stem Cell Transplantation

  2004cites this paper
• Real‐Time Polymerase Chain Reaction

  2003cites this paper